RSCM
Rock Springs Capital Management’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-400,000
| Closed | -$6.02M | – | 118 |
|
|
2024
Q3 | $6.02M | Sell |
400,000
-385,000
| -49% | -$5.79M | 0.2% | 79 |
|
|
2024
Q2 | $22.5M | Sell |
785,000
-270,500
| -26% | -$7.74M | 0.68% | 47 |
|
|
2024
Q1 | $30.8M | Hold |
1,055,500
| – | – | 0.78% | 43 |
|
|
2023
Q4 | $35.6M | Hold |
1,055,500
| – | – | 0.88% | 40 |
|
|
2023
Q3 | $32.4M | Buy |
1,055,500
+20,500
| +2% | +$629K | 0.87% | 36 |
|
|
2023
Q2 | $41.5M | Buy |
1,035,000
+2,400
| +0.2% | +$96.2K | 0.99% | 34 |
|
|
2023
Q1 | $42.1M | Hold |
1,032,600
| – | – | 1.01% | 35 |
|
|
2022
Q4 | $39.9M | Buy |
1,032,600
+15,100
| +1% | +$583K | 0.96% | 39 |
|
|
2022
Q3 | $54.1M | Hold |
1,017,500
| – | – | 1.4% | 21 |
|
|
2022
Q2 | $59.3M | Buy |
1,017,500
+17,500
| +2% | +$1.02M | 1.73% | 16 |
|
|
2022
Q1 | $76.3M | Hold |
1,000,000
| – | – | 1.92% | 14 |
|
|
2021
Q4 | $60.2M | Hold |
1,000,000
| – | – | 1.39% | 21 |
|
|
2021
Q3 | $56M | Sell |
1,000,000
-25,000
| -2% | -$1.4M | 1.18% | 28 |
|
|
2021
Q2 | $62.2M | Hold |
1,025,000
| – | – | 1.23% | 23 |
|
|
2021
Q1 | $71.8M | Hold |
1,025,000
| – | – | 1.57% | 21 |
|
|
2020
Q4 | $61.3M | Buy |
1,025,000
+20,000
| +2% | +$1.2M | 1.3% | 24 |
|
|
2020
Q3 | $60.4M | Buy |
1,005,000
+80,000
| +9% | +$4.81M | 1.53% | 17 |
|
|
2020
Q2 | $48.5M | Buy |
925,000
+25,000
| +3% | +$1.31M | 1.33% | 20 |
|
|
2020
Q1 | $30.2M | Sell |
900,000
-250,000
| -22% | -$8.38M | 1.25% | 31 |
|
|
2019
Q4 | $52.1M | Hold |
1,150,000
| – | – | 1.65% | 11 |
|
|
2019
Q3 | $43.8M | Sell |
1,150,000
-100,000
| -8% | -$3.81M | 1.74% | 10 |
|
|
2019
Q2 | $54.4M | Hold |
1,250,000
| – | – | 1.97% | 8 |
|
|
2019
Q1 | $47.6M | Hold |
1,250,000
| – | – | 1.83% | 9 |
|
|
2018
Q4 | $53.8M | Sell |
1,250,000
-42,479
| -3% | -$1.83M | 2.54% | 8 |
|
|
2018
Q3 | $63.5M | Buy |
1,292,479
+94,479
| +8% | +$4.64M | 2.3% | 9 |
|
|
2018
Q2 | $38.4M | Buy |
1,198,000
+73,000
| +6% | +$2.34M | 1.48% | 17 |
|
|
2018
Q1 | $35M | Buy |
1,125,000
+18,300
| +2% | +$570K | 1.49% | 18 |
|
|
2017
Q4 | $50.5M | Buy |
1,106,700
+18,700
| +2% | +$854K | 2.29% | 6 |
|
|
2017
Q3 | $40.9M | Buy |
1,088,000
+45,500
| +4% | +$1.71M | 1.88% | 11 |
|
|
2017
Q2 | $49.7M | Buy |
1,042,500
+42,500
| +4% | +$2.03M | 2.51% | 6 |
|
|
2017
Q1 | $45.6M | Buy |
1,000,000
+287,000
| +40% | +$13.1M | 2.63% | 5 |
|
|
2016
Q4 | $23M | Buy |
713,000
+209,000
| +41% | +$6.75M | 1.54% | 23 |
|
|
2016
Q3 | $17.2M | Buy |
504,000
+31,500
| +7% | +$1.08M | 1.08% | 30 |
|
|
2016
Q2 | $15.9M | Buy |
472,500
+146,000
| +45% | +$4.92M | 1.18% | 24 |
|
|
2016
Q1 | $17.3M | Buy |
326,500
+66,500
| +26% | +$3.52M | 1.45% | 18 |
|
|
2015
Q4 | $20M | Buy |
260,000
+92,000
| +55% | +$7.06M | 1.51% | 20 |
|
|
2015
Q3 | $6.91M | Buy |
168,000
+100,000
| +147% | +$4.11M | 0.56% | 63 |
|
|
2015
Q2 | $4.81M | Buy |
68,000
+17,250
| +34% | +$1.22M | 0.35% | 92 |
|
|
2015
Q1 | $4.51M | Buy |
+50,750
| New | +$4.51M | 0.42% | 76 |
|
|
2014
Q4 | – | Sell |
-102,000
| Closed | -$9.89M | – | 99 |
|
|
2014
Q3 | $9.89M | Buy |
102,000
+24,250
| +31% | +$2.35M | 1.53% | 21 |
|
|
2014
Q2 | $7.14M | Buy |
77,750
+16,750
| +27% | +$1.54M | 1.28% | 25 |
|
|
2014
Q1 | $4.27M | Buy |
61,000
+10,500
| +21% | +$735K | 0.98% | 34 |
|
|
2013
Q4 | $2.9M | Buy |
+50,500
| New | +$2.9M | 1.04% | 28 |
|